Poster presentations include dose optimization data for novel Wee1/Myt1 co-inhibitor SGR-3515 and the first characterization of SGR-4174, a novel SOS1 inhibitor CHICAGO--(BUSINESS WIRE)--Schrödinger, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results